284 related articles for article (PubMed ID: 33547327)
1. Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.
Opron K; Begley LA; Erb-Downward JR; Freeman C; Madapoosi S; Alexis NE; Barjaktarevic I; Graham Barr R; Bleecker ER; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper DJ; Doerschuk CM; Dransfield MT; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kaner RJ; Krishnan J; O'Neal WK; Ortega VE; Paine R; Peters SP; Michael Wells J; Woodruff PG; Martinez FJ; Curtis JL; Huffnagle GB; Huang YJ
NPJ Biofilms Microbiomes; 2021 Feb; 7(1):14. PubMed ID: 33547327
[TBL] [Abstract][Full Text] [Related]
2. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
Madapoosi SS; Cruickshank-Quinn C; Opron K; Erb-Downward JR; Begley LA; Li G; Barjaktarevic I; Barr RG; Comellas AP; Couper DJ; Cooper CB; Freeman CM; Han MK; Kaner RJ; Labaki W; Martinez FJ; Ortega VE; Peters SP; Paine R; Woodruff P; Curtis JL; Huffnagle GB; Stringer KA; Bowler RP; Esther CR; Reisdorph N; Huang YJ;
Am J Respir Crit Care Med; 2022 Aug; 206(4):427-439. PubMed ID: 35536732
[No Abstract] [Full Text] [Related]
3. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
Erb-Downward JR; Thompson DL; Han MK; Freeman CM; McCloskey L; Schmidt LA; Young VB; Toews GB; Curtis JL; Sundaram B; Martinez FJ; Huffnagle GB
PLoS One; 2011 Feb; 6(2):e16384. PubMed ID: 21364979
[TBL] [Abstract][Full Text] [Related]
4. Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort.
Ronish BE; Couper DJ; Barjaktarevic IZ; Cooper CB; Kanner RE; Pirozzi CS; Kim V; Wells JM; Han MK; Woodruff PG; Ortega VE; Peters SP; Hoffman EA; Buhr RG; Dolezal BA; Tashkin DP; Liou TG; Bateman LA; Schroeder JD; Martinez FJ; Barr RG; Hansel NN; Comellas AP; Rennard SI; Arjomandi M; Paine Iii R
Chronic Obstr Pulm Dis; 2022 Apr; 9(2):111-121. PubMed ID: 35114743
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.
Zakharkina T; Heinzel E; Koczulla RA; Greulich T; Rentz K; Pauling JK; Baumbach J; Herrmann M; Grünewald C; Dienemann H; von Müller L; Bals R
PLoS One; 2013; 8(7):e68302. PubMed ID: 23874580
[TBL] [Abstract][Full Text] [Related]
6. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
[TBL] [Abstract][Full Text] [Related]
7. Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS.
Zhang WZ; Oromendia C; Kikkers SA; Butler JJ; O'Beirne S; Kim K; O'Neal WK; Freeman CM; Christenson SA; Peters SP; Wells JM; Doerschuk C; Putcha N; Barjaktarevic I; Woodruff PG; Cooper CB; Bowler RP; Comellas AP; Criner GJ; Paine R; Hansel NN; Han MK; Crystal RG; Kaner RJ; Ballman KV; Curtis JL; Martinez FJ; Cloonan SM
Sci Rep; 2020 Jun; 10(1):10562. PubMed ID: 32601308
[TBL] [Abstract][Full Text] [Related]
8. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
Einarsson GG; Comer DM; McIlreavey L; Parkhill J; Ennis M; Tunney MM; Elborn JS
Thorax; 2016 Sep; 71(9):795-803. PubMed ID: 27146202
[TBL] [Abstract][Full Text] [Related]
9. Characterization of throat microbial flora in smokers with or without COPD.
Diao W; Shen N; Du Y; Qian K; He B
Int J Chron Obstruct Pulmon Dis; 2017; 12():1933-1946. PubMed ID: 28740374
[TBL] [Abstract][Full Text] [Related]
10. Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.
Wu X; Wei X; Li X; Deng J; Zhang J
Jpn J Infect Dis; 2022 Nov; 75(6):560-568. PubMed ID: 35908874
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
Pirozzi CS; Gu T; Quibrera PM; Carretta EE; Han MK; Murray S; Cooper CB; Tashkin DP; Kleerup EC; Barjaktarevic I; Hoffman EA; Martinez CH; Christenson SA; Hansel NN; Graham Barr R; Bleecker ER; Ortega VE; Martinez FJ; Kanner RE; Paine R;
Respir Res; 2018 Nov; 19(1):223. PubMed ID: 30454050
[TBL] [Abstract][Full Text] [Related]
12. Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome.
Engel M; Endesfelder D; Schloter-Hai B; Kublik S; Granitsiotis MS; Boschetto P; Stendardo M; Barta I; Dome B; Deleuze JF; Boland A; Müller-Quernheim J; Prasse A; Welte T; Hohlfeld J; Subramanian D; Parr D; Gut IG; Greulich T; Koczulla AR; Nowinski A; Gorecka D; Singh D; Gupta S; Brightling CE; Hoffmann H; Frankenberger M; Hofer TP; Burggraf D; Heiss-Neumann M; Ziegler-Heitbrock L; Schloter M; Zu Castell W
PLoS One; 2017; 12(7):e0180859. PubMed ID: 28704452
[TBL] [Abstract][Full Text] [Related]
13. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
[TBL] [Abstract][Full Text] [Related]
14. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
[TBL] [Abstract][Full Text] [Related]
15. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
Lee SW; Kuan CS; Wu LS; Weng JT
PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
[TBL] [Abstract][Full Text] [Related]
16. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
[TBL] [Abstract][Full Text] [Related]
17. Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?
Sethi S
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S43-7. PubMed ID: 24437405
[TBL] [Abstract][Full Text] [Related]
18. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.
Pragman AA; Lyu T; Baller JA; Gould TJ; Kelly RF; Reilly CS; Isaacson RE; Wendt CH
Microbiome; 2018 Jan; 6(1):7. PubMed ID: 29316977
[TBL] [Abstract][Full Text] [Related]
19. COPD and the microbiome.
Mammen MJ; Sethi S
Respirology; 2016 May; 21(4):590-9. PubMed ID: 26852737
[TBL] [Abstract][Full Text] [Related]
20. The impact of Sangju Qingjie Decoction on the pulmonary microbiota in the prevention and treatment of chronic obstructive pulmonary disease.
Liu Z; Huang Y; Hu C; Liu X
Front Cell Infect Microbiol; 2024; 14():1379831. PubMed ID: 38746785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
